Team is advising Global Top 25 Pharmaceutical and Biotech Company on various legal aspects of medicines pricing, procurement and reimbursement reform, introduction of the National Essential Medicines List and expected transformation in state funding of rare diseases treatment. link

Marchenko Danevych team advises a global healthcare leader Lilly on a number of simplified marketing authorization procedures recently introduced in Ukraine. link

As part of a consortium of international experts established and financed by EBRD, Marchenko Danevych’s lawyers applied their expertise to the unprecedented attempt to improve the medicines registration system of Ukraine. link

Marchenko Danevych advised one of the Top 5 Global pharmaceutical companies on the dispute resolution strategy to challenge unfair competition practices of a competing undertaking controlled by Ukrainian and U.S. investors. link

Marchenko Danevych has been acting for a Top 10 Global pharmaceutical company in the domestic litigation with the Ministry of Health of Ukraine and in the related investor-state dispute. link

The team advised global pharmaceutical giant Novo Nordisk on various matters relating to compliant and transparent interactions with healthcare professionals and healthcare organizations in Ukraine. link

This site uses cookies. An explanation of their purpose can be found within Terms of Use